The importance of drug-transporting P-glycoproteins in toxicology

被引:43
作者
van Tellingen, O [1 ]
机构
[1] Netherlands Canc Inst, Dept Clin Chem, Antoni Van Leeuwenhoek Huis, NL-1066 CX Amsterdam, Netherlands
关键词
P-glycoprotein; multidrug resistance; knockout mice; protective function;
D O I
10.1016/S0378-4274(01)00304-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The importance of specific transport in toxicology is becoming increasingly clear and the work on P-glycoprotein has certainly been a major contribution to these growing insights. P-Glycoproteins were discovered by their ability to confer multidrug resistance in mammalian tumour cells. They are localised in the cell membrane where they actively extrude a wide range of compounds including many anti-cancer drugs from the cell. Besides in tumour cells, drug-transporting P-glycoploteins are also expressed in a polarised fashion in normal tissues that perform an excretory or barrier function, such as the liver, kidneys, intestines, brain endothelial cells. Based on this expression profile, it has been proposed that P-glycoproteins are important in protecting the host by reducing exposure to xenobiotics. Further studies with P-glycoprotein knockout mice have clearly established this protective function. In general, the clearance of substrate drugs is lower in knockout mice due to a diminished hepatobiliary excretion, direct intestinal excretion and/or increased enterohepatic cycling. Moreover, their uptake in sanctuary sites, such as the brain or the foetus, was profoundly higher in P-glycoprotein knockout mice, as was the uptake of drugs from the gastro-intestinal tract into the systemic circulation following oral ingestion. These results clearly highlight the impact that transport proteins can play in toxicology. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 77 条
[51]   Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins [J].
Schinkel, AH ;
Mayer, U ;
Wagenaar, E ;
Mol, CAAM ;
vanDeemter, L ;
Smit, JJM ;
vanderValk, MA ;
Voordouw, AC ;
Spits, H ;
vanTellingen, O ;
Zijlmans, JMJM ;
Fibbe, WE ;
Borst, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :4028-4033
[52]   DISRUPTION OF THE MOUSE MDR1A P-GLYCOPROTEIN GENE LEADS TO A DEFICIENCY IN THE BLOOD-BRAIN-BARRIER AND TO INCREASED SENSITIVITY TO DRUGS [J].
SCHINKEL, AH ;
SMIT, JJM ;
VANTELLINGEN, O ;
BEIJNEN, JH ;
WAGENAAR, E ;
VANDEEMTER, L ;
MOL, CAAM ;
VANDERVALK, MA ;
ROBANUSMAANDAG, EC ;
TERIELE, HPJ ;
BERNS, AJM ;
BORST, P .
CELL, 1994, 77 (04) :491-502
[53]  
Schuetz EG, 2000, MOL PHARMACOL, V57, P188
[54]   A general pattern for substrate recognition by P-glycoprotein [J].
Seelig, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 251 (1-2) :252-261
[55]  
SHARMA RC, 1992, J BIOL CHEM, V267, P5731
[56]   The P-glycoprotein efflux pump: How does it transport drugs? [J].
Sharom, FJ .
JOURNAL OF MEMBRANE BIOLOGY, 1997, 160 (03) :161-175
[57]   Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein [J].
Sikic, BI ;
Fisher, GA ;
Lum, BL ;
Halsey, J ;
BeketicOreskovic, L ;
Chen, G .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) :S13-S19
[58]   HOMOZYGOUS DISRUPTION OF THE MURINE MDR2 P-GLYCOPROTEIN GENE LEADS TO A COMPLETE ABSENCE OF PHOSPHOLIPID FROM BILE AND TO LIVER-DISEASE [J].
SMIT, JJM ;
SCHINKEL, AH ;
ELFERINK, RPJO ;
GROEN, AK ;
WAGENAAR, E ;
VANDEEMTER, L ;
MOL, CAAM ;
OTTENHOFF, R ;
VANDERLUGT, NMT ;
VANROON, MA ;
VANDERVALK, MA ;
OFFERHAUS, GJA ;
BERNS, AJM ;
BORST, P .
CELL, 1993, 75 (03) :451-462
[59]   Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption [J].
Smit, JW ;
Schinkel, AH ;
Müller, M ;
Weert, B ;
Meijer, DKF .
HEPATOLOGY, 1998, 27 (04) :1056-1063
[60]   Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure [J].
Smit, JW ;
Huisman, MT ;
van Tellingen, O ;
Wiltshire, HR ;
Schinkel, AH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (10) :1441-1447